Location History:
- Toyonaka, JP (2019)
- Osaka, JP (2021 - 2024)
Company Filing History:
5 out of 1,001 
2 out of 1,285 
2 out of 984 
Years Active: 2019-2025
Title: Yusuke Tateno: Innovator in Pharmaceutical Chemistry
Introduction
Yusuke Tateno is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential. With a total of five patents to his name, Tateno's work focuses on addressing various health issues through innovative chemical solutions.
Latest Patents
Tateno's latest patents include a dihydropyrazolopyrazinone derivative that exhibits MGAT2 inhibitory activity. This invention provides a compound represented by a specific formula, which is crucial for its medicinal properties. Another notable patent involves a fused ring derivative that also demonstrates MGAT-2 inhibitory activity. The compounds developed by Tateno are designed to treat MGAT2-associated diseases, including obesity, metabolic syndrome, hyperlipidemia, hypertriglyceridemia, hyper-VLDL-triglyceridemia, hyperfattyacidemia, diabetes mellitus, and arteriosclerosis.
Career Highlights
Throughout his career, Tateno has worked with esteemed organizations such as Shionogi & Company Limited and The University of Tokyo. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Tateno's notable coworkers include Tetsuo Nagano and Takayoshi Okabe. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical compounds.
Conclusion
Yusuke Tateno's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for new treatments for various health conditions.